intercept pharmaceuticals

  1. Intercept Pharmaceuticals

    AnYour know about the Intercept contract? Salary? Bonus? Company Car vs allowance? Credit score required?
  2. NASH

    Nonalcoholic steatohepatitis (NASH) liver fibrosis is the new golden goose in the biotech space. More than 40 companies are taking part in clinical trials to bring the first NASH drug to market. Very few of them are close to seeing some success. NASH’s market value is set to increase to $21.5...
  3. Gilead failed, but Intercept succeeded

    Last week, Gilead failed in Phase 3 clinical trial for NASH drug. Today, Intercept has become the first player in the NASH area to complete a pivotal Phase 3 study in patients with liver fibrosis.